Home 2023

Psoriasis

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market
Artificial Intelligence

AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market

Uduak Thomas -
0
Melanoma Survival Rate Boosted by Memory Cells
Cancer

Melanoma Survival Rate Boosted by Memory Cells

Christina Jackson -
0
Amgen Vows to Fight Back as FTC Takes Aim at $27.8B Horizon Deal
Drug Discovery

Amgen Vows to Fight Back as FTC Takes Aim at $27.8B Horizon Deal

Alex Philippidis -
28
Type 1 Diabetes May Be Treatable with Immunological Drug
News

Type 1 Diabetes May Be Treatable with Immunological Drug

John Sterling -
0
Novel Drug Delivery Method Could Replace Injections with Pills
Drug Discovery

Novel Drug Delivery Method Could Replace Injections with Pills

John Sterling -
0
Immune Protein Found to Be a Driver of Inflammation
News

Immune Protein Found to Be a Driver of Inflammation

Christina Jackson -
0
Building Better Bispecifics
Bioprocessing

Building Better Bispecifics

John Sterling -
0
Psoriasis Therapeutic Could Tweak an Alternate Target in a Trio
Drug Discovery

Psoriasis Therapeutic Could Tweak an Alternate Target in a Trio

Anjali A. Sarkar, PhD -
0
Asthma Worsens with Repurposed Drug Licensed for Psoriasis
Drug Discovery

Asthma Worsens with Repurposed Drug Licensed for Psoriasis

Anjali A. Sarkar, PhD -
0
123...9Page 1 of 9
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.